Cancer Antibodies Combination Therapies Clinical Research Market Size Insight
January 05, 2024 07:09 ET
|
KuicK Research
Delhi, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Global Cancer Antibody Combinations Market Opportunity & Clinical Trials Insight 2028 Report Findings & Highlights: Global Cancer Antibody...
Combination Cancer Therapy Clinical Trials Therapies Research Report 2028
June 09, 2022 07:19 ET
|
KuicK Research
Singapore, June 09, 2022 (GLOBE NEWSWIRE) -- Global Combination Cancer Immunotherapy Market Opportunity & Clinical Trials Insight 2028 Report Highlights: Global & Regional Combination...
Combination Cancer Therapy Market Insight 2028
June 09, 2022 05:42 ET
|
KuicK Research
Singapore, June 09, 2022 (GLOBE NEWSWIRE) -- Global Combination Cancer Immunotherapy Market Opportunity & Clinical Trials Insight 2028 Report Highlights: Global & Regional Combination...
Provectus Biopharmaceuticals Expands Global Patent Portfolio to India for Cancer Combination Therapy
June 09, 2020 09:00 ET
|
Provectus Biopharmaceuticals Inc.
2020 India patent follows 2018 India patent that protects Provectus’ proprietary API manufacturing processProvectus further expands cancer combination therapy IP protection by filing new USPTO patent...
PROVECTUS BIOPHARMACEUTICALS EXPANDS GLOBAL PATENT PORTFOLIO FOR CANCER COMBINATION THERAPY
April 18, 2018 06:00 ET
|
Provectus Biopharmaceuticals Inc.
FOR IMMEDIATE RELEASE KNOXVILLE, TN, April 18, 2018 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.provectusbio.com) (“Provectus” or the “Company”), a clinical-stage...